DaVita Inc
SWB:TRL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
DaVita Inc (TRL) under the Base Case is EUR per share.
Compared with the current market price of 160.95 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What DaVita Does
DaVita is a healthcare company focused on kidney care. Its main business is running dialysis centers, where it treats patients whose kidneys can no longer clean waste from the blood properly. It also offers related care services for people with chronic kidney disease, including support before dialysis starts and help managing long-term treatment.
- Headquarters
- United States of America US
- Employees
- 78 000
- IPO date
- Oct 31, 1995
DaVita has a narrow economic moat
Buying supplies in bulk and spreading support costs across its clinics help DaVita deliver dialysis more cheaply than smaller providers. In some communities, existing clinics already serve much of the available patient population, leaving little room for a newcomer to operate profitably. These protections are stronger against small entrants than against its large rival, Fresenius Medical Care.
Read the full moat analysis
Revenue & Expenses Breakdown
DaVita Inc
Earnings Waterfall
DaVita Inc
What is the Intrinsic Value of one TRL stock?
The intrinsic value for DaVita Inc (TRL) under the Base Case is EUR.
Is TRL stock undervalued or overvalued?
Compared with the current market price of 160.95 EUR, the stock appears .
